Lifetec Group 797725 - 500 Beiträge pro Seite

[stellwerk]

Lifetec Group Ltd.,kennt die jemand und was machen die so,
in HK heute über 354 Mil.gehandelte Stck. und +27%,in Berlin
kein Umsatz,Chart sieht in HK gut aus,weiss jemand näheres?

[asiate]

Hey

letzte Meldung:

Hong Kong-listed LifeTec sells subsidiary for 18.87 mln hkd

HONG KONG (AFX-ASIA) - Hong Kong-listed LifeTec Group Ltd said wholly-owned subsidiary LifeTec (Holdings) Ltd has agreed to sell the entire issued share capital of Durable Stock Investments Ltd (DSI) for 18.87 mln hkd.

The purchaser is independent party Angels` Investing Ltd, which is not connected to LifeTec Group or its directors, the company said in a statement.

The purchaser will pay the 18.87 mln hkd for the stake by transferring to LifeTec (Holdings) 15.732 mln shares for 1.20 hkd each in Sen Hong Resources Holdings Ltd, a company listed on Hong Kong`s main board.

The shares have a par value of 0.01 usd each -- the figure of 1.20 hkd being the stock`s average closing price for the ten trading days up to Dec 30.

LifeTec said it expects to record a gain of about 16.8 mln hkd from the disposal. It also said it has not decided whether to dispose of the Sen Hong shares or to hold them as long term investment.

Under the agreement, LifeTec Group will also transfer its 100 pct interest in Shanghai Youheng Biotechnology Ltd to an investment holding company Golden Butterfly Investments Ltd.

LifeTec is engaged in the development and sales of pharmaceutical products in China.


zum Unternehmen:



The principal activities of the Group are engaged in: (i) the research and development, manufacture and sale of biopharmaceutical products operated under its subsidiary, Weihai Sinogen Pharmaceutical ("Sinogen"); (ii) general trading and PVC business; and (iii) the development and trading of computer hardware and software operated under its associate, LT3000 Online.
For the FYE 12/2002, the Group achieved a great an 38.9% increase in sales as compared with previous year and it also recorded a 59.3% reduction of net loss to HK$23.3mn (2001: net loss amounted to HK$57.3mn). This remarkable improvement was mainly attributed to the contribution from Sinogen. In Aug 2002, the Group completed the construction of the Sinogen`s new production plant, which significantly increased its capacity from 2mn vials per annum to approx. 20mn vials per annum. This new production volume is expected to be sufficient to meet the anticipated growth in demand in the coming few years. In Oct 2002, the new plant also formally obtained the GMP certificate. The Group expects that the sales of its flagship product - "Wei Jia", will continue to achieve healthy growth in 2003. Moreover, the recent launch of the R & D of the DNA recombinant version of "Wei Jia" and follow-up downstream development work also paved the way for future expansion into leading regions of the world. In order to be more focused on the biopharmaceutical business, the Group will continue to seek for suitable buyers for its trading and PVC division and its interest in LT3000 Online.


http://www.hk1180.com/

Bis dann

[stellwerk]

Danke